Replies to post #649374 on NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

Thanks for taking the time to respond. But unfortunately you still need to make it much simpler. OK, I get that the purple CSF1R-I made a big difference - much better. Then you point out that the FDA approved CSF1R-I brought no revenue to Daiichi so far - not so good. So where are you going with this about CSF1R-I ? In any case, please explain how CSF1R-I relates to DCVAX-L that I should be interested in it?

[georgebailey]

D stock question for you and Antonio dissertation.
The red line must be without Poly. Should I conclude Poly was omitted entirely in this study?
Am I correct that the combos represented as purple is being tested with the addition of Poly at UCLA and same has not begun enrollment yet?
Thank you